Announcement under Regulation 30 (LODR)-Preferential Issue
Filed with BSE · ISIN INE365Y01019 · · 12 pages · English
Summary by 6ix AI
Bharat Parenterals Ltd. has filed a disclosure regarding the approval of resolutions from their Extraordinary General Meeting held recently. The resolutions include the issuance of equity shares on a preferential basis and making investments beyond specified limits under the Companies Act. The filing includes voting results and a report from the Scrutinizer confirming the outcomes of the votes cast.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
This is to inform you that the resolutions mentioned (as stated below) in the Notice of the Extraordinary General Meeting (“EGM”) dated October 01, 2026 read with corrigendum dated October 13, 2026 (“EGM Notice”), has been approved by the shareholders with requisite majority at their EGM held today i.e. Friday, October 23, 2026. a) Issuance of equity shares of the Company on preferential basis, an
Bharat Parenterals Ltd. on 6ix
Story so far
Earlier from Bharat Parenterals
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On September 30, 2026.
- Shareholder Meeting / Postal Ballot-Outcome of EGM
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
Later from Bharat Parenterals
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Board Meeting Outcome for Outcome Of Board Meeting
- Announcement under Regulation 30 (LODR)-Investor Presentation
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Clarification On Price Movement
Follow Bharat Parenterals into a list and get an email when it puts out news.
Follow Bharat Parenterals